RNASET2 and posterior cortical atrophy: Our findings underscore the RNASET2’s dual functionality, acting through both cell-autonomous and non-cell autonomous mechanisms in PCa in vitro and in vivo models and suggest its potential as a therapeutic target in a subset of PCa.